Team:UCL

From 2013.igem.org

(Difference between revisions)
Line 162: Line 162:
<div id="container">
<div id="container">
 +
 +
<!-- START CONTENT ---------------------------------------------------------------------------------------------------->
<!-- START CONTENT ---------------------------------------------------------------------------------------------------->
<div id="artwork">
<div id="artwork">
Line 187: Line 189:
<div id="sunshine3"><a href="http://2013.igem.org/Team:UCL/Memories"></a></div>
<div id="sunshine3"><a href="http://2013.igem.org/Team:UCL/Memories"></a></div>
<div id="sunshine4"><a href="http://2013.igem.org/Team:UCL/Memories"></a></div>
<div id="sunshine4"><a href="http://2013.igem.org/Team:UCL/Memories"></a></div>
 +
</div>
 +
 +
<p class="major_title">IGEM: INTELLIGENTLY GENETICALLY ENGINEERED MICROGLIA</p>
 +
<p class="minor_title">Synthetic Biology Fights Alzheimer's Disease</p>
 +
 +
<p class="abstract_text" style="color:#404040;">
 +
This year, the UCL iGEM team is taking a radical new step with synthetic biology. We intend to explore the potential application genetic engineering techniques on the brain, because it is the site of some of the most subtle, and many of the most devastating medical conditions. Alzheimer’s Disease is a neurodegenerative disease characterised by the loss of recent memory and intellectual functions. We have devised a genetic circuit for transfection into microglia, a novel chassis in which standard assembly has never been used, to boost their ability to break down senile plaques, which are associated with Alzheimer’s disease, as well as to support and protect endangered neurons from microglia-mediated neuroinflammation.
 +
<br><br>
 +
</p>
 +
<p class="abstract_text" style="color:#C14645;">
 +
Click the abstracts below to read more.
 +
</p>
 +
</div>
</div>

Revision as of 12:02, 4 October 2013

IGEM: INTELLIGENTLY GENETICALLY ENGINEERED MICROGLIA

Synthetic Biology Fights Alzheimer's Disease

This year, the UCL iGEM team is taking a radical new step with synthetic biology. We intend to explore the potential application genetic engineering techniques on the brain, because it is the site of some of the most subtle, and many of the most devastating medical conditions. Alzheimer’s Disease is a neurodegenerative disease characterised by the loss of recent memory and intellectual functions. We have devised a genetic circuit for transfection into microglia, a novel chassis in which standard assembly has never been used, to boost their ability to break down senile plaques, which are associated with Alzheimer’s disease, as well as to support and protect endangered neurons from microglia-mediated neuroinflammation.

Click the abstracts below to read more.